company background image
BLT logo

BLIS Technologies NZSE:BLT Stock Report

Last Price

NZ$0.016

Market Cap

NZ$20.5m

7D

14.3%

1Y

-33.3%

Updated

24 Jul, 2024

Data

Company Financials

BLIS Technologies Limited

NZSE:BLT Stock Report

Market Cap: NZ$20.5m

BLT Stock Overview

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

BLT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

BLIS Technologies Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BLIS Technologies
Historical stock prices
Current Share PriceNZ$0.016
52 Week HighNZ$0.027
52 Week LowNZ$0.014
Beta0.47
11 Month Change-5.88%
3 Month Change-5.88%
1 Year Change-33.33%
33 Year Change-77.78%
5 Year Change-68.00%
Change since IPO-98.38%

Recent News & Updates

BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Dec 05
BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Recent updates

BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Dec 05
BLIS Technologies (NZSE:BLT) Is In A Strong Position To Grow Its Business

Calculating The Intrinsic Value Of BLIS Technologies Limited (NZSE:BLT)

Mar 08
Calculating The Intrinsic Value Of BLIS Technologies Limited (NZSE:BLT)

BLIS Technologies Limited (NZSE:BLT) Insiders Have Been Selling

Feb 09
BLIS Technologies Limited (NZSE:BLT) Insiders Have Been Selling

BLIS Technologies Limited (NZSE:BLT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Jan 21
BLIS Technologies Limited (NZSE:BLT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

I Ran A Stock Scan For Earnings Growth And BLIS Technologies (NZSE:BLT) Passed With Ease

Jan 03
I Ran A Stock Scan For Earnings Growth And BLIS Technologies (NZSE:BLT) Passed With Ease

Should You Use BLIS Technologies's (NZSE:BLT) Statutory Earnings To Analyse It?

Dec 15
Should You Use BLIS Technologies's (NZSE:BLT) Statutory Earnings To Analyse It?

Introducing BLIS Technologies (NZSE:BLT), The Stock That Soared 371% In The Last Three Years

Nov 28
Introducing BLIS Technologies (NZSE:BLT), The Stock That Soared 371% In The Last Three Years

Shareholder Returns

BLTNZ PharmaceuticalsNZ Market
7D14.3%1.9%1.5%
1Y-33.3%55.2%-1.0%

Return vs Industry: BLT underperformed the NZ Pharmaceuticals industry which returned 55.2% over the past year.

Return vs Market: BLT underperformed the NZ Market which returned -1% over the past year.

Price Volatility

Is BLT's price volatile compared to industry and market?
BLT volatility
BLT Average Weekly Movement11.4%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement4.8%
10% most volatile stocks in NZ Market8.7%
10% least volatile stocks in NZ Market3.0%

Stable Share Price: BLT has not had significant price volatility in the past 3 months.

Volatility Over Time: BLT's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

FoundedEmployeesCEOWebsite
200039Scott Johnsonwww.blis.co.nz

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Middle East, Africa, and North America.

BLIS Technologies Limited Fundamentals Summary

How do BLIS Technologies's earnings and revenue compare to its market cap?
BLT fundamental statistics
Market capNZ$20.47m
Earnings (TTM)NZ$646.00k
Revenue (TTM)NZ$11.57m

31.7x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLT income statement (TTM)
RevenueNZ$11.57m
Cost of RevenueNZ$2.25m
Gross ProfitNZ$9.32m
Other ExpensesNZ$8.67m
EarningsNZ$646.00k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.00051
Gross Margin80.55%
Net Profit Margin5.58%
Debt/Equity Ratio0%

How did BLT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.